Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers

• Váldodahkkit: Jun Wu (Dahkki), Jinghua Lu (Dahkki), Qiuyue Chen (Dahkki), Haojie Chen (Dahkki), Yongqiang Zheng (Dahkki), Minggang Cheng (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BackgroundCLDN18.2 is a widely researched drug target. However, previous research has primarily been based on immunohistochemistry results and focused on gastric cancer.MethodsTo analyze the potential cancer-targeting effect of CLDN18.2 from a multi-omics perspective, this study quantified CLDN18.2...